Tag: Aspirin

For those aged 40 to 59 years, the decision to initiate low-dose aspirin for primary prevention of CVD should be individualized

Largest benefits seen for patients older than 60 years with no increased risk for hemorrhagic complications

Findings inconclusive for subgroup analysis looking at safety of ceasing regular aspirin use without a clinical indication after age 70 years

Compared with placebo, daily aspirin did not improve invasive disease-free survival in patients with high-risk, HER2-negative breast cancer

No increased risk for tinnitus seen with low-dose aspirin, but increase seen with moderate-dose aspirin for those younger than 60 years, NSAIDS, acetaminophen

Findings reported among women at high risk due to prepregnancy diabetes, obesity, and/or chronic hypertension

Authors urge primary care physicians to make case-by-case basis decisions based on benefit-to-risk

Aspirin use associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease

Low-dose aspirin has substantial benefit for reducing risk for preeclampsia, preterm birth, IUGR, perinatal mortality

Fixed-dose combo with BP-lowering meds, statin, and aspirin yields largest reduction in cardiovascular risk